« Back
Home /
INT-767

INT-767

Manufacturer	MedChem Express
Category	Metabolism Diabetes Cholesterol & Lipid Metabolism Inhibitors & Compound Libraries Small Molecules Other Lipid\Cholesterol Metabolism Modulators
Type	Inhibitors
Specific against	other
Amount	50 mg
Item no.	HY-12434-50mg
Targets	FXR; GPCR19; Autophagy
CASRN	1000403-03-1
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	INT-767 is a dual farnesoid X receptor (FXR)/TGR5 agonist with mean EC50s of 30 and 630 nM, respectively[1][2].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	494.66
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer
Solubility	DMSO : ≥ 100 mg/mL\|H2O : 100 mg/mL (ultrasonic)
Manufacturers Target	Autophagy; FXR; G protein-coupled Bile Acid Receptor 1
Pathway	Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12434-50mg-safety-datasheet.pdf